AstraZeneca to List Shares in New York but Keep London Base
The logo for AstraZeneca outside its North America headquarters in Wilmington, Del., on Mar. 22, 2021. Rachel Wisniewski/Reuters AstraZeneca announced on Sept. 29 that it will list its ordinary shares directly on the New York Stock Exchange, replacing its American depository receipts, but said it is not abandoning London. AstraZeneca, the UK’s second-biggest listed company